drug value

Market Access

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Views & Analysis

Addressing the data and evidence gap in the early stages of asset development.

News

Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy rare epilepsy drug developer Actio Bio for $820m upfront.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.